ASAM Weekly for July 11th, 2023
July 13, 2023
July 13, 2023
CHEVY CHASE, Maryland, July 13 (TNSjou) -- The American Society of Addiction Medicine issued the following ASAM Weekly roundup:
Attention to xylazine is coalescing because of the combined harms that come with fentanyl. A new study in rats shows how the alpha-2 agonist may contribute to opioid deaths by eliminating a compensatory mechanism for opioid-induced brain hypoxia, leading to a stronger and more prolonged hypoxic state (Psychopharmacology). How this works in humans is importa . . .
Attention to xylazine is coalescing because of the combined harms that come with fentanyl. A new study in rats shows how the alpha-2 agonist may contribute to opioid deaths by eliminating a compensatory mechanism for opioid-induced brain hypoxia, leading to a stronger and more prolonged hypoxic state (Psychopharmacology). How this works in humans is importa . . .